Institutional Ownership Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). We have compiled data on the 188 institutions that hold shares in the stock, with a total of 79.7 Million shares, which have been reported (via 13F filing form) to have a value of $1.34 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
5,380,449
shares
|
$90.3 Million
2.54% of portfolio
|
Q1 2025
Added 18.96%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,773,622
shares
|
$80.1 Million
0.0% of portfolio
|
Q2 2024
Added 25.21%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
4,700,000
shares
|
$78.9 Million
5.34% of portfolio
|
Q1 2025
Added 41.3%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
4,563,100
shares
|
$76.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.7%
|
|
|
Vr Adviser, LLC
New York, NY |
May 15, 2025 Q1 2025 |
3,882,709
shares
|
$65.2 Million
12.64% of portfolio
|
Q3 2024
Added 0.0%
|
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
3,600,000
shares
|
$60.4 Million
4.75% of portfolio
|
Q1 2025
Added 50.0%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
May 15, 2025 Q1 2025 |
3,445,813
shares
|
$57.9 Million
15.82% of portfolio
|
Q3 2024
Added 86.68%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,865,500
shares
|
$48.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 18.65%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
2,792,925
shares
|
$46.9 Million
2.44% of portfolio
|
Q1 2025
Added 12.03%
|
|
|
Novo Holdings
Hellerup, G7 |
May 15, 2025 Q1 2025 |
2,250,300
shares
|
$37.8 Million
2.73% of portfolio
|
Q1 2025
Added 0.01%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
2,095,079
shares
|
$35.2 Million
1.45% of portfolio
|
Q1 2025
Added 15.11%
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
May 15, 2025 Q1 2025 |
2,061,274
shares
|
$34.6 Million
0.55% of portfolio
|
Q1 2025
Added 0.36%
|
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
2,021,619
shares
|
$33.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.6%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,720,525
shares
|
$28.9 Million
0.0% of portfolio
|
Q1 2025
Added 3.71%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,688,129
shares
|
$28.3 Million
0.0% of portfolio
|
Q1 2025
Added 27.23%
|
|
|
Eversept Partners, LP
New York, NY |
May 15, 2025 Q1 2025 |
1,377,674
shares
|
$23.1 Million
2.05% of portfolio
|
Q1 2025
Added 76.63%
|
|
|
Loomis Sayles & CO L P
|
May 14, 2025 Q1 2025 |
1,370,356
shares
|
$23 Million
0.03% of portfolio
|
Q1 2025
Reduced 2.14%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
1,270,481
shares
|
$21.3 Million
0.19% of portfolio
|
Q1 2025
Reduced 32.27%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
1,248,721
shares
|
$21 Million
0.02% of portfolio
|
Q4 2024
Added 21.79%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
1,231,092
shares
|
$20.7 Million
0.0% of portfolio
|
Q1 2025
Added 33.8%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
1,114,586
shares
|
$18.7 Million
0.03% of portfolio
|
Q1 2025
Reduced 33.26%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
1,084,040
shares
|
$18.2 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
1,064,506
shares
|
$17.9 Million
1.86% of portfolio
|
Q1 2025
Reduced 2.13%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,061,517
shares
|
$17.8 Million
0.03% of portfolio
|
Q2 2023
Added 1.78%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
May 12, 2025 Q1 2025 |
982,576
shares
|
$16.5 Million
3.6% of portfolio
|
Q4 2024
Reduced 41.45%
|